Akute zerebrale Ischämie – Diagnostik und Therapie

Abstract

Der Patient mit einem akuten Schlaganfall ist als medizinischer Notfall zu behandeln und sollte in eine Schlaganfallstation (Stroke Unit) eingewiesen und dort behandelt werden. Der Schlaganfall ist die dritthäufigste Todesursache, entscheidend für das Outcome der Patienten ist die reibungslose Akuttherapie.Ca. 1/3 der Patienten erreichen eine Klinik im therapierbaren Zeitfenster.Die intravenöse Thrombolyse im akuten Stadium ist eine etablierte und durch große randomisierte Studien validierte Therapie. Die neuen invasiven, interventionellen Techniken zur Thrombektomie sind vielversprechend, der Stellenwert in der Schlaganfalltherapie muss jedoch noch durch randomisierte Studien belegt werden.Dieser Beitrag erläutert, wie Sie einen ischämischen Schlaganfall strukturiert diagnostizieren und behandeln.

Schlüsselwörter:

Schlaganfall - akute zerebrale Ischämie - Therapie - Diagnose - Thrombolyse - Thrombektomie

• Literatur

• 1 Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329
• 2 Wahlgren N, Ahmed N, Dávalos A et al. Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372: 1303-1309
• 3 National Institutes of Health. NIH Stroke Scale. 2003. Im Internet: http://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf dt.Version: http://www.neurologie-wittlich.de/seiten/doku/NIHSS.pdf Stand 0.12.2014
• 4 Keller DM. “MR CLEAN“ polishes stroke outcome with endovascular therapy. Medscape (29.10.2014). Im Internet: http://www.medscape.com/viewarticle/834064 Stand 0.12.2014
• 5 Jüttler E, Bösel J, Amiri H et al. DESTINY II: DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY II. Int J Stroke 2011; 6: 79-86
• 6 Adams HP, delZoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Resaerch Interdisciplinary Working Groups. Scientific statement from the Stroke Council of the American Stroke Association. Stroke 2007; 38: 1655-1711
• 7 Ahmed N, Wahlgren N, Brainin M et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke 2009; 40: 2442-2449
• 8 Barber PA, Zhang J, Demchuk AM et al. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001; 56: 1015-1020
• 9 Bergui M, Stura G, Daniele D et al. Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first-line treatment. Stroke 2006; 37: 145-150
• 10 Brandt T, von Kummer R, Müller Küppers M et al. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996; 27: 875-881
• 11 Davalos A, Toni D, Iweins F et al. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke 1999; 30: 2631-2636
• 12 Diener HC, Weimar C. Leitlinien für Diagnostik und Therapie in der Neurologie. 5. Aufl. Stuttgart: Thieme; 2012
• 13 Dirks M, Niessen LW, van Wijngaarden JDH et al. Promoting thrombolysis in acute ischemic stroke. Stroke 2011; 42: 1325-1330
• 14 Easton JD, Saver JL, Albers GW et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40: 2276-2293
• 15 Giles MF, Albers GW, Amarenco P et al. Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Neurology 2011; 77: 1222-1228
• 16 Gupta R, Connolly ES, Mayer S et al. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke 2004; 35: 539-543
• 17 Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: Pooled analysis of atlantis, ecass, and nindsrt-pa stroke trials. Lancet 2004; 363: 768-774
• 18 Jüttler E, Schwab S, Schmiedek P et al. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke 2007; 38: 2518-2525
• 19 Lees KR, Bluhmki E, Kummer von R et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-1703
• 20 Mattle HP, Arnold M, Lindsberg PJ et al. Basilar artery occlusion. Lancet Neurol 2011; 10: 1002-1014
• 21 Nakano S, Iseda T, Yoneyama T et al. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 2002; 33: 2872-2876
• 22 National Institute of Neurological Disorders and Stroke (NINDS). Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke 1996. Im Internet: http: //www.ninds.nih.gov/news_and_events/proceedings/stroke_proceedings/recs-acute.htm Stand 0.12.2014
• 23 Nogueira RG, Lutsep HL, Gupta R et al. Trevo versus Merci retrievers for thrombectomyrevascularisation of large vessel occlusions in acute ischaemic stroke (TREVOR 2): a randomised trial. Lancet 2012; 380: 1231-1240
• 24 Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40: 2761-2768
• 25 Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a metaanalysis. Stroke 2007; 38: 967-973
• 26 Rimmele L, Thomalla G. Wake-up Stroke: clinical characteristics, imaging findings and treatment option – an update. Front Neurol 2014; 5: 35-35
• 27 Saver JL, Jahan R, Levy El et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241-1249
• 28 Stampfl S, Hartmann M, Ringleb PA et al. Stent placement for flow restoration in acute ischemic stroke; a single-center experience with the Solitaire stent system. AJNR Am J Neuroradiol 2011; 32: 1245-1248
• 29 Stroke Unit Trialists' Collaboration. Organized inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev CD 000197 2007; 4
• 30 Thomalla G, Cheng B, Ebinger M et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4,5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol 2011; 10: 978-986
• 31 Uhl E, Kreth FW, Elias B et al. Outcome and prognostic factors of hemicraniectomy for space occupying cerebral infarction. JNNP 2004; 75: 270-274
• 32 Wahlgren N, Ahmed N, Dávalos A et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-282